Unexplained weight loss (UWL), defined as a loss of more than 5% of body weight over a period of 6-12 months without a clear cause, is a common yet perplexing issue encountered in clinical practice. It can be the harbinger of a serious underlying illness, making its evaluation crucial for clinicians.
UWL can be attributed to myriad causes, broadly categorized into three groups: malignancy, non-malignant gastrointestinal diseases, and psychiatric disorders. Other causes include endocrine disorders, chronic infections, and drugs. However, in approximately 15-25% of cases, no cause is identified despite extensive evaluation.
The initial assessment should involve a comprehensive history and physical examination, focusing on symptoms of potential underlying conditions. Detailed dietary history, drug history, and psychosocial assessment are also essential. If the initial evaluation does not reveal a cause, laboratory tests, imaging studies, and endoscopic procedures may be warranted based on clinical suspicion.
Diagnostic imaging plays a pivotal role in the evaluation of UWL. Computed tomography (CT) of the chest, abdomen, and pelvis is often the first-line imaging modality, given its ability to detect malignancies and other systemic diseases. However, the choice of imaging should be guided by individual patient characteristics and clinical suspicion.
The management of UWL is primarily directed towards treating the underlying cause. In cases where no cause is identified, symptomatic management and regular follow-up are recommended. The follow-up strategy should be individualized based on the patient's age, comorbidities, and clinical progress.
Unexplained weight loss is a complex clinical issue that requires a systematic and comprehensive approach for evaluation. A thorough history, physical examination, and appropriate use of diagnostic tools are key to identifying the underlying cause. In cases where no cause is identified, a patient-centered approach focusing on symptom management and regular follow-up is essential.
1.
Both men and women who receive the HPV vaccine have a lower risk of developing multiple cancer types.
2.
Potentially Novel Approach for Treating Advanced Colorectal Cancer with KRAS Mutations.
3.
CAR-T cell therapy for cancer causes 'brain fog,' study shows
4.
In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.
5.
Cancer research in the US is world class. With the government pulling out, its future is uncertain
1.
Environmental Carcinogen Exposure Risk Modeling: Current Evidence and Clinical Implications
2.
Screening for Cancer-Related Neuromuscular Weakness: Clinical Approaches and Evidence-Based Strategies
3.
A Closer Look at White Blood Cells in Urine: Uncovering the Causes and Treatments
4.
The Silent Killer: Uncovering the Causes and Treatments of Hemorrhagic Gastritis
5.
Exploring The Causes and Consequences of Low Transferrin Saturation
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation